Fragment hopping protocol for the design of small-molecule protein-protein interaction inhibitors.

Bioorg Med Chem

Drug Discovery Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, United States; Department of Chemistry, University of South Florida, Tampa, FL 33620, United States. Electronic address:

Published: September 2022

Fragment-based ligand discovery (FBLD) is one of the most successful approaches to designing small-molecule protein-protein interaction (PPI) inhibitors. The incorporation of computational tools to FBLD allows the exploration of chemical space in a time- and cost-efficient manner. Herein, a computational protocol for the development of small-molecule PPI inhibitors using fragment hopping, a fragment-based de novo design approach, is described and a case study is presented to illustrate the efficiency of this protocol. Fragment hopping facilitates the design of PPI inhibitors from scratch solely based on key binding features in the PPI complex structure. This approach is an open system that enables the inclusion of different state-of-the-art programs and softwares to improve its performances.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2022.116879DOI Listing

Publication Analysis

Top Keywords

fragment hopping
12
ppi inhibitors
12
small-molecule protein-protein
8
protein-protein interaction
8
hopping protocol
4
protocol design
4
design small-molecule
4
inhibitors
4
interaction inhibitors
4
inhibitors fragment-based
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!